Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Levetiracetam NDC 51224-013 by Tagi Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 01
This text provides the number of patients and the dosage in two different groups (one with placebo, one with Levetiracetam) for a study evaluating the efficacy of Levetiracetam in seizure treatment. However, there is not enough information to determine the results or conclusions of the study.*
image 02
image 03
The text shows a table with the percentage of patients on a placebo (N=104) and those on Levetiracetam 3,000 mg/day (N=180). The percentages go from 0% to 45%. There is no further information available.*
image 04
The text represents a chart that compares the percentage of patients who were administered either a placebo or Levetiracetam. The percentage values range from 0% to 45% and are in 5% increments. The chart shows that 19.6% of patients who were administered the placebo experienced the desired effect. The number of patients in the placebo group was 97, while the number of patients administered Levetiracetam was 101.*
image 05
The text presents the percentage of patients who took a placebo or Levetiracetam. The placebo group had 51 participants and had a 19.6% result, while the Levetiracetam group had 58 participants with a 43.1% outcome.*
image 06
This text provides percentages of patients for two different groups, Placebo (N=84) and Levetiracetam (N=79). However, there is no context or further information to explain what these percentages represent.*
image 07
This appears to be a description of a medication called TAGI Phama, which contains 500mg of levetiracetam, 8.2mg of sodium acetate, 45mg of sodium chloride, and glacial acetic acid for pH adjustment, with a recommended dose for intravenous use only. Each box contains ten single-dose vials, each of which is 5mL in volume, and must be diluted before administration. It's recommended that unused portions be discarded, and the product should be stored between 15-30°C (59-86°F).*
image 08
levetiracetam
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
